The Pharma & Healthcare industry is of vital importance for human and economic development, providing a wide range of goods and services relevant to the promotion of health at all stages in the healthcare process – from prevention and treatment to rehabilitation and palliative care. It is one of the fastest-growing industries, supported by profound demographic changes, the rising incidence of non-communicable diseases, and surging per capita health spending in both developed and emerging markets. The industry is also one of the major innovators, with increasing expenditures on development of new molecules, biotechnology and adoption of new technologies that provide advanced healthcare and ensure the longevity of the population.
The Pharma & Healthcare industry comprises the manufacture of pharmaceuticals for human and veterinary use, medical equipment and related supplies. It also includes providers of ambulatory health services, medical and diagnostic laboratories, hospitals, and nursing and residential care facilities.
India’s pharmaceuticals and healthcare sector has a global reputation. India accounts for approximately 20% of the worldwide market share of generic drugs, making it the leading exporter, particularly to the developing world. India is ...View more details
In the context of Latin America, Chile is not a particularly large pharmaceutical and healthcare market as its population is relatively small and healthy in terms of incidence of communicable diseases. However, the country’s changing ...View more details
The COVID-19 pandemic underlined the inefficiencies of the Brazilian pharmaceutical and healthcare sector. In drug manufacturing, many pharmaceutical companies took a hit in profitability. They struggled to meet demand as global supply chains were ...View more details
Thailand’s pharmaceuticals and healthcare sector has developed considerably over the past few decades. The Thai government initiated its plan to deliver universal healthcare to all Thais in 2002, which has proven so successful that more than 99 ...View more details
Russia’s healthcare expenditure grew significantly in 2020, mainly reflecting increased spending related to the COVID-19 pandemic. Total spending on healthcare surged by nearly a fifth to RUB 6.2tn in 2020, equal to 5.8% of the country’s ...View more details
Malaysia has a highly developed pharmaceuticals and healthcare sector. Malaysia’s healthcare system is two-tiered. The Ministry of Health (“MoH”) provides comprehensive, taxpayer-funded healthcare services for Malaysian ...View more details
In Q3 2021, Chinese residents’ expenditures on medicine and medical services continued to increase. Per capita spending of urban residents reached RMB 635, up by 10.8% y/y, and that of rural residents recorded a growth of 9 ...View more details